» Articles » PMID: 30220049

Receptor Pharmacophore Ensemble (REPHARMBLE): a Probabilistic Pharmacophore Modeling Approach Using Multiple Protein-ligand Complexes

Overview
Journal J Mol Model
Publisher Springer
Specialty Molecular Biology
Date 2018 Sep 17
PMID 30220049
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Ensemble methods are gaining more importance in structure-based approaches as single protein-ligand complexes strongly influence the outcomes of virtual screening. Structure-based pharmacophore modeling based on a single protein-ligand complex with complex feature combinations is often limited to certain chemical classes. The REPHARMBLE (receptor pharmacophore ensemble) approach presented here examines the ability of an ensemble of selected protein-ligand complexes to populate pharmacophore space in the ligand binding site, rigorously assesses the importance of pharmacophore features using Poisson statistic and information theory-based entropy calculations, and generates pharmacophore models with high probabilities. In addition, an ensemble scoring function that combines all the resultant high-scoring pharmacophore models to score molecules is derived. The REPHARMBLE approach was evaluated on ten DUD-E benchmark datasets and afforded good screening performance, as measured by receiver operating characteristic, enrichment factor and Güner-Henry score. Although one of the high-scoring models achieved superior statistical results in each dataset, the ensemble scoring function balanced the shortcomings of each model and passed with close performance measures. This approach offers a reliable way of choosing the best-scoring features to build four-feature pharmacophore queries and customize a target-biased 'pharmacophore ensemble' scoring function for subsequent virtual screening.

Citing Articles

Identification of novel inhibitors targeting PI3Kα via ensemble-based virtual screening method, biological evaluation and molecular dynamics simulation.

Zhang H, Qi H, Li Y, Shi X, Hu M, Chen X J Comput Aided Mol Des. 2024; 38(1):37.

PMID: 39528618 DOI: 10.1007/s10822-024-00580-2.


Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking.

Qiu G, Yu L, Jia L, Cai Y, Chen Y, Jin J Mol Divers. 2024; 29(2):1353-1373.

PMID: 39009908 DOI: 10.1007/s11030-024-10918-5.


Integration of the Butina algorithm and ensemble learning strategies for the advancement of a pharmacophore ligand-based model: an investigation of apelin agonists.

Tran X, Phan T, To V, Tran N, Nguyen N, Nguyen D Front Chem. 2024; 12:1382319.

PMID: 38690013 PMC: 11058650. DOI: 10.3389/fchem.2024.1382319.


Identification of new potent NLRP3 inhibitors by multi-level in-silico approaches.

Hayat C, Subramaniyan V, Alamri M, Shing Wong L, Khalid A, Abdalla A BMC Chem. 2024; 18(1):76.

PMID: 38637900 PMC: 11027297. DOI: 10.1186/s13065-024-01178-3.


Targeting Streptomyces-Derived Streptenol Derivatives against Gynecological Cancer Target PIK3CA: An In Silico Approach.

Christy H, Vasudevan S, Sudha S, Kandeel M, Subramanian K, Pugazhvendan S Biomed Res Int. 2022; 2022:6600403.

PMID: 35860806 PMC: 9293527. DOI: 10.1155/2022/6600403.


References
1.
Wang J, Wang W, Kollman P, Case D . Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model. 2006; 25(2):247-60. DOI: 10.1016/j.jmgm.2005.12.005. View

2.
Meslamani J, Li J, Sutter J, Stevens A, Bertrand H, Rognan D . Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling. J Chem Inf Model. 2012; 52(4):943-55. DOI: 10.1021/ci300083r. View

3.
Leong M . A novel approach using pharmacophore ensemble/support vector machine (PhE/SVM) for prediction of hERG liability. Chem Res Toxicol. 2007; 20(2):217-26. DOI: 10.1021/tx060230c. View

4.
Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

5.
. 'Fuzziness' in pharmacophore-based virtual screening and de novo design. Drug Discov Today Technol. 2013; 7(4):e203-70. DOI: 10.1016/j.ddtec.2010.10.004. View